Advice You
#1 in Business Subscribe Email Print

You are here: Home > Internet and Businesses Online > Link Popularity > Link Exchanges - Good or Bad?

Tags

  • patients
  • right
  • google wants
  • exchange links
  • google wants

  • Links

  • The Business Mindset
  • Exercise Plan Tips
  • Webpage Templates-Best Answer For Your Website Design?
  • Advice You - Link Exchanges - Good or Bad?

    All too often a hot thread will pop up in a forum where another worried, confused, trying-to-do-it-right webmaster is asking
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    the "experts" about Google's policy regarding link exchanges. Every time the question of linking comes up, a line is drawn in
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    the sand, and the two sides go at it.

    Here are a couple of typical responses:

    "I still think getting links is
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    a good idea. There are some topics on the web that that's all visitors do is follow links."

    "Link exchanges will end up kill
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ing a site, many people who have them find themselves under a penalty now."

    Very seldom will anyone from either
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    side of the link exchange issue offer definite proof of their argument. Each post is colored with slight variations on the de
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    gree to which it is bad or good. Each poster tries desperately to establish some credibility for themselves while arguing tha
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    t their actions and decisions are the RIGHT way and this leads quickly to another heated, circular debate with no clear winne
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    rs. This leaves the person asking the original question more confused than they were when they asked it in the first place.

    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    Frankly, no one has any idea what Google, or any other search engine, will like or not like. What worked before may not work
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ow, and no one can give a definitive answer as to why. As the old Zen master once said, "It is what it is."

    Now logic dictat
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    es that Google does not want to penalize sites engaging in link exchanges. What Google wants is to please the people that rel
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    y on them to provide a quality resource.

    How does exchanging links or the avoidance of the practice, define a quality resour
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ce? It doesn't. People define a quality resource, and therein lies the answer to what approach one should take regarding exch
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    anging links.

    As a person you are completely competent to know when exchanging a link increases or decreases the quality of
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    our web site. If anything you do, including linking to a web site that links to you, increases the quality, that is good. If
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    the exchanging of links decreases the quality, that is bad.

    Remember this: You have every right to do whatever you think is
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    best for your web site.

    You can't control Google, but you can control your site. If you exchange links or do not exchange li
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    nks because you think it will make Google do something, your chances of losing at some point go way up. If you exchange links
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    or don't exchange links because it makes your site better, then you win. And doesn't it make sense that Google wants winners


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.adviceyou.org.ua/article/70793/adviceyou-Link-Exchanges--Good-or-Bad.html">Link Exchanges - Good or Bad?</a>

    BB link (for phorums):
    [url=http://www.adviceyou.org.ua/article/70793/adviceyou-Link-Exchanges--Good-or-Bad.html]Link Exchanges - Good or Bad?[/url]

    Related Articles:

    It's About Jobs!

    Branding - The Single Most Important Thing

    Prescription for Success: The Role of the Pharmacy Call in Pharmaceutical Sales

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com

    wymiana linkow nieautoryzowano sprawdz autoryzacje no auth no auth